APPCO Pharma LLC
US H-1B Labor Condition Application activity for APPCO Pharma LLC. Filed 261 disclosures between FY2013 and FY2025 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of APPCO Pharma LLC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 92.7% |
| Cert-withdrawn | 1.1% |
| Withdrawn | 6.1% |
Top occupations sponsored
SOC codes filed most by APPCO Pharma LLC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 186 |
| 2 | 15-1253 | Software Quality Assurance Analysts and Testers | 16 |
| 3 | 13-1041 | Compliance Officers | 12 |
| 4 | 19-4021 | Biological Technicians | 4 |
| 5 | 19-1022 | Microbiologists | 3 |
| 6 | 17-2041 | Chemical Engineers | 3 |
| 7 | 19-1012 | Food Scientists and Technologists | 2 |
| 8 | 13-1111 | Management Analysts | 2 |
| 9 | 17-2141 | Mechanical Engineers | 2 |
| 10 | 11-3021 | Computer and Information Systems Managers | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2013 | 38 |
| FY2014 | 14 |
| FY2015 | 36 |
| FY2016 | 41 |
| FY2017 | 30 |
| FY2018 | 28 |
| FY2019 | 18 |
| FY2020 | 5 |
| FY2022 | 8 |
| FY2023 | 2 |
| FY2024 | 31 |
| FY2025 | 10 |
| Period | Value |
|---|---|
| FY2013 | 38 |
| FY2014 | 14 |
| FY2015 | 36 |
| FY2016 | 41 |
| FY2017 | 30 |
| FY2018 | 28 |
| FY2019 | 18 |
| FY2020 | 5 |
| FY2022 | 8 |
| FY2023 | 2 |
| FY2024 | 31 |
| FY2025 | 10 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.